These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 27576739)
1. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643 [TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab. Wittström E; Holmberg H; Hvarfner C; Andréasson S Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613 [TBL] [Abstract][Full Text] [Related]
4. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)]. Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145 [TBL] [Abstract][Full Text] [Related]
6. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma. Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917 [TBL] [Abstract][Full Text] [Related]
8. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. Alkawas AA; Shahien EA; Hussein AM J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624 [TBL] [Abstract][Full Text] [Related]
9. What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study. Shi L; Yang J; Lin J BMC Ophthalmol; 2019 Jun; 19(1):128. PubMed ID: 31185956 [TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor for neovascular glaucoma. Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392 [TBL] [Abstract][Full Text] [Related]
11. A review of neovascular glaucoma. Etiopathogenesis and treatment. Dumbrăveanu L; Cușnir V; Bobescu D Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma. Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Eid TM; Radwan A; el-Manawy W; el-Hawary I Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma. Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572 [TBL] [Abstract][Full Text] [Related]
15. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Kitnarong N; Chindasub P; Metheetrairut A Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438 [TBL] [Abstract][Full Text] [Related]
16. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512 [TBL] [Abstract][Full Text] [Related]
17. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma. Wasik A; Song HF; Grimes A; Engelke C; Thomas A Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229 [TBL] [Abstract][Full Text] [Related]
18. Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization. Sun C; Zhang H; Tang Y; Chen Y; Li Y; Nie C; Gu J; Luo L; Wang Z Curr Eye Res; 2020 Dec; 45(12):1504-1513. PubMed ID: 32339463 [No Abstract] [Full Text] [Related]
19. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma. Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888 [TBL] [Abstract][Full Text] [Related]
20. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Gupta V; Jha R; Rao A; Kong G; Sihota R Eur J Ophthalmol; 2009; 19(3):435-41. PubMed ID: 19396791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]